Search results
HanxBio announces the publication of a research paper in Scientific Reports on preclinical...
ABC 26 New Orleans· 6 days agoHanxBio today announced that it has published a research article titled "Narazaciclib, a novel multikinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML ...
MorphoSys Says Novartis Deal Progressing Steadily Despite Safety Concerns Over Bone Marrow Cancer...
Benzinga· 2 hours agoMorphoSys AG MOR is reportedly facing a burgeoning safety concern surrounding pelabresib, an...
Affimed (NASDAQ:AFMD) Short Interest Update
ETF DAILY NEWS· 15 hours agoAffimed (NASDAQ:AFMD – Get Free Report) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totalling 219,400 shares, an increase ...
Deverra Therapeutics Granted FDA Fast Track Designation for DVX101
Digital Journal· 5 days agoDesignation Validates Preliminary Data and Supports Accelerated Drug Development SEATTLE, WA / ACCESSWIRE / April 24, 2024 / Deverra Therapeutics, Inc., a clinical-stage biotechnology company ...
Study reveals insights into DDX41 protein's role in blood cancer pathogenesis
Medical Xpress· 6 days agoA study led by Professors Hongtae Kim and JaYil Lee from the Department of Biological Sciences, in collaboration with researchers from the Catholic University of Korea, sheds light on the pivotal ...
Cullinan Oncology, Inc. (NASDAQ:CGEM) Sees Large Growth in Short Interest
ETF DAILY NEWS· 15 hours agoCullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 1,680,000 shares ...
Vor Biopharma’s (VOR) “Outperform” Rating Reiterated at Wedbush
ETF DAILY NEWS· 4 days agoWedbush reissued their outperform rating on shares of Vor Biopharma (NYSE:VOR – Free Report) in a research report released on Tuesday, Benzinga reports. Wedbush currently has a $11.00 price ...
Secondary cancer: Why breast cancer survivors have a higher risk
Medical News Today· 4 days agoThe age of cancer diagnosis appears to affect second cancer risk, especially for women, as does economic status. In it, researchers from the University of Cambridge in England report that women ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoSAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will
Coffee Memorial Blood Center seeks platelet donations amid low supply
KAMR Amarillo· 6 days agoOfficials with the Coffee Memorial Blood Center asked community members to donate blood platelets...